3-Hydroxy-1,2-Dimethyl-4(1H)-Pyridone

Deferiprone is primarily used for:

• Treatment of Iron Overload: It is indicated for patients with thalassemia major who require chelation therapy due to excessive iron accumulation from blood transfusions.
• Combination Therapy: It can be used alongside other chelators when monotherapy is ineffective or contraindicated.
• Potential Antiviral Activity: Research into its effects on HIV indicates possible applications beyond iron chelation.

Deferiprone's primary biological activity is its ability to chelate iron effectively. It has been shown to lower serum ferritin levels and improve iron status in patients with thalassemia and other conditions requiring blood transfusions. Additionally, recent studies suggest that deferiprone may have antiviral properties, specifically in reactivating apoptosis in HIV-infected cells.

• Absorption: Rapid absorption occurs in the upper gastrointestinal tract.
• Half-life: Approximately 1.9 hours.
• Excretion: About 75-90% of the drug is excreted through the kidneys within 24 hours.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.